BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28291546)

  • 1. Acute toxicity and surgical complications after preoperative (chemo)radiation therapy for rectal cancer in patients with inflammatory bowel disease.
    Bosch SL; van Rooijen SJ; Bökkerink GM; Braam HJ; Derikx LA; Poortmans P; Marijnen CA; Nagtegaal ID; de Wilt JH
    Radiother Oncol; 2017 Apr; 123(1):147-153. PubMed ID: 28291546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04).
    Ansari N; Solomon MJ; Fisher RJ; Mackay J; Burmeister B; Ackland S; Heriot A; Joseph D; McLachlan SA; McClure B; Ngan SY
    Ann Surg; 2017 May; 265(5):882-888. PubMed ID: 27631775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant long-course chemoradiation remains strongly favored over short-course radiotherapy by radiation oncologists in the United States.
    Mowery YM; Salama JK; Zafar SY; Moore HG; Willett CG; Czito BG; Hopkins MB; Palta M
    Cancer; 2017 Apr; 123(8):1434-1441. PubMed ID: 27984651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectal cancer and inflammatory bowel disease: natural history and implications for radiation therapy.
    Green S; Stock RG; Greenstein AJ
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):835-40. PubMed ID: 10386640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative Chemoradiotherapy for Rectal Cancer in Patients Aged 75 Years and Older: Acute Toxicity, Compliance with Treatment, and Early Results.
    Guimas V; Boustani J; Schipman B; Lescut N; Puyraveau M; Bosset JF; Servagi-Vernat S
    Drugs Aging; 2016 Jun; 33(6):419-25. PubMed ID: 27138958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the irradiated small bowel volume still a predictor for acute lower gastrointestinal toxicity during preoperative concurrent chemo-radiotherapy for rectal cancer when using intensity-modulated radiation therapy?
    Xu B; Guo Y; Chen Y; Lu H; Tang T; Yue Z; Guan G; Chi P; Lin C
    Radiat Oncol; 2015 Dec; 10():257. PubMed ID: 26684643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Toxicity in Inflammatory Bowel Disease Patients Treated With Abdominal and Pelvic Radiation Therapy.
    White EC; Murphy JD; Chang DT; Koong AC
    Am J Clin Oncol; 2015 Dec; 38(6):564-9. PubMed ID: 24401668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: a multi-institutional phase II study (KROG 04-01).
    Lee JH; Kim DY; Nam TK; Yoon SC; Lee DS; Park JW; Oh JH; Chang HJ; Yoon MS; Jeong JU; Jang HS
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):955-61. PubMed ID: 22537540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: results from a randomized Phase III study.
    Brændengen M; Tveit KM; Bruheim K; Cvancarova M; Berglund Å; Glimelius B
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1017-24. PubMed ID: 20932687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Matched Case-Control Analysis of Clinical Outcomes for Patients With Inflammatory Bowel Disease and Rectal Cancer Treated With Pelvic Radiation Therapy.
    Mudgway R; Bryant AK; Heide ES; Riviere P; O'Hare C; Rose BS; Murphy JD; Simpson DR
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):994-1004. PubMed ID: 31461672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
    Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
    J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local recurrence after five years is associated with preoperative chemoradiotherapy treatment in patients diagnosed with stage II and III rectal cancer.
    Marin G; Suárez J; Vera R; Balén E; Viudez A; Mata E
    Int J Surg; 2017 Aug; 44():15-20. PubMed ID: 28583894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Health-Related Quality of Life in Patients With Rectal Cancer After Preoperative Short-Course and Long-Course (Chemo) Radiotherapy.
    Wiltink LM; Nout RA; van der Voort van Zyp JR; Ceha HM; Fiocco M; Meershoek-Klein Kranenbarg E; Marinelli AW; van de Velde CJ; Marijnen CA
    Clin Colorectal Cancer; 2016 Sep; 15(3):e93-9. PubMed ID: 26968237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small bowel dose parameters predicting grade ≥ 3 acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation: an independent validation study comparing peritoneal space versus small bowel loop contouring techniques.
    Banerjee R; Chakraborty S; Nygren I; Sinha R
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1225-31. PubMed ID: 23182394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?
    Wan J; Liu K; Li K; Li G; Zhang Z
    Radiat Oncol; 2015 Aug; 10():162. PubMed ID: 26238572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of pelvic wall and bowel fibrosis with bowel obstruction induced by neoadjuvant chemoradiotherapy for rectal carcinoma].
    Chi P; Chen Z; Gao Y; Lin H; Lu X; Huang Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Nov; 18(11):1092-7. PubMed ID: 26616800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Metastasis- and Disease-Free Survival With Preoperative Sequential Short-Course Radiation Therapy and FOLFOX Chemotherapy for Rectal Cancer Compared With Neoadjuvant Long-Course Chemoradiotherapy: Results of a Matched Pair Analysis.
    Markovina S; Youssef F; Roy A; Aggarwal S; Khwaja S; DeWees T; Tan B; Hunt S; Myerson RJ; Chang DT; Parikh PJ; Olsen JR
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):417-426. PubMed ID: 28871992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delaying surgery after neoadjuvant chemoradiotherapy in rectal cancer has no influence in surgical approach or short-term clinical outcomes.
    Figueiredo N; Panteleimonitis S; Popeskou S; Cunha JF; Qureshi T; Beets GL; Heald RJ; Parvaiz A
    Eur J Surg Oncol; 2018 Apr; 44(4):484-489. PubMed ID: 29398323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEA - a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer.
    Wallin U; Rothenberger D; Lowry A; Luepker R; Mellgren A
    Dis Colon Rectum; 2013 Jul; 56(7):859-68. PubMed ID: 23739192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.